Shanghai HeartCare Medical Technology Past Earnings Performance
Past criteria checks 0/6
Shanghai HeartCare Medical Technology has been growing earnings at an average annual rate of 5.1%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been growing at an average rate of 60.5% per year.
Key information
5.1%
Earnings growth rate
21.6%
EPS growth rate
| Medical Equipment Industry Growth | 13.7% |
| Revenue growth rate | 60.5% |
| Return on equity | -8.7% |
| Net Margin | -40.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
We're Not Very Worried About Shanghai HeartCare Medical Technology's (HKG:6609) Cash Burn Rate
Jan 23
Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609) Shares May Have Slumped 27% But Getting In Cheap Is Still Unlikely
Aug 30Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
Aug 09Companies Like Shanghai HeartCare Medical Technology (HKG:6609) Are In A Position To Invest In Growth
May 07We're Hopeful That Shanghai HeartCare Medical Technology (HKG:6609) Will Use Its Cash Wisely
Nov 29Revenue & Expenses BreakdownBeta
How Shanghai HeartCare Medical Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 232 | -94 | 154 | 124 |
| 30 Sep 23 | 224 | -141 | 160 | 143 |
| 30 Jun 23 | 216 | -188 | 165 | 163 |
| 31 Mar 23 | 199 | -194 | 167 | 158 |
| 31 Dec 22 | 183 | -200 | 168 | 154 |
| 30 Sep 22 | 160 | -185 | 155 | 129 |
| 30 Jun 22 | 137 | -169 | 142 | 105 |
| 31 Mar 22 | 115 | -188 | 146 | 92 |
| 31 Dec 21 | 90 | -194 | 135 | 76 |
| 30 Sep 21 | 66 | -242 | 176 | 75 |
| 30 Jun 21 | 43 | -290 | 217 | 73 |
| 31 Mar 21 | 28 | -244 | 179 | 60 |
| 31 Dec 20 | 15 | -214 | 156 | 51 |
Quality Earnings: 6609 is currently unprofitable.
Growing Profit Margin: 6609 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6609 is unprofitable, but has reduced losses over the past 5 years at a rate of 5.1% per year.
Accelerating Growth: Unable to compare 6609's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6609 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-8.3%).
Return on Equity
High ROE: 6609 has a negative Return on Equity (-8.74%), as it is currently unprofitable.